COM:RELMADA
Relmada Therapeutics, Inc.
- Stock
Last Close
3.50
31/10 20:00
Market Cap
128.54M
Beta: -
Volume Today
67.59K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
revenue | |||||||||||
cost of revenue | 4.87K - | 3.75K - | 1.26K 66.47% | ||||||||
gross profit | -4.87K - | -3.75K - | -1.26K 66.47% | ||||||||
selling and marketing expenses | 12.31M - | ||||||||||
general and administrative expenses | 9.23M - | 10.01M 8.48% | 5.93M 40.80% | 3.97M 32.92% | 5.70M 43.48% | 7.25K 99.87% | 24.87M 342,885.23% | 35.08M 41.08% | 47.93M 36.61% | 36.59M 23.66% | |
selling general and administrative expenses | 9.23M - | 10.01M 8.48% | 5.93M 40.80% | 3.97M 32.92% | 5.70M 43.48% | 7.25K 99.87% | 24.87M 342,885.23% | 35.08M 41.08% | 47.93M 36.61% | 48.89M 2.02% | |
research and development expenses | 7.87M - | 6.21M 21.16% | 1.29M 79.16% | 2.94M 127.49% | 7.02M 138.72% | 7.86K 99.89% | 35.97M 457,600.19% | 90.62M 151.92% | 113.32M 25.05% | 54.81M 51.64% | |
other expenses | 130.27K - | 216.21K 65.97% | 2.35K 98.91% | 6.35M - | |||||||
cost and expenses | 17.10M - | 16.22M 5.17% | 7.22M 55.48% | 6.92M 4.17% | 12.73M 84.00% | 15.11K 99.88% | 60.84M 402,565.12% | 125.70M 106.62% | 161.25M 28.28% | 103.70M 35.69% | |
operating expenses | 17.10M - | 16.22M 5.17% | 7.22M 55.48% | 6.92M 4.17% | 12.73M 84.00% | 15.11K 99.88% | 60.84M 402,565.12% | 125.70M 106.62% | 161.25M 28.28% | 103.70M 35.69% | |
interest expense | 4.92K - | 1.34M - | |||||||||
ebitda | -13.38M - | -29.27M 118.76% | -7.85M 73.18% | -6.21M 20.95% | -8.89M 43.31% | -15.10K 99.83% | -60.82M 402,536.11% | -124.45M 104.63% | -156.44M 25.70% | -103.70M 33.71% | |
operating income | -17.10M - | -16.22M 5.17% | -7.22M 55.48% | -6.92M 4.17% | -12.73M 84.00% | -15.11K 99.88% | -60.84M 402,556.83% | -125.70M 106.62% | -161.25M 28.28% | -103.70M 35.69% | |
depreciation and amortization | 9.26K - | 54.82K 492.25% | 85.27K 55.55% | 2.63K 96.92% | 4.87K 85.38% | 4.36 99.91% | 3.75K 85,895.87% | 1.26K 66.47% | 4.81M 381,917.25% | ||
total other income expenses net | -3.71M - | 13.24M 456.82% | 932.86K 92.95% | -706.55K 175.74% | -3.83M 441.94% | 104.11 100.00% | -16.95K 16,376.70% | -1.25M 7,260.99% | 1.55M 223.92% | 4.91M 217.66% | |
income before tax | -20.80M - | -2.97M 85.70% | -6.29M 111.33% | -8.96M 42.54% | -17.32M 93.26% | -15.01K 99.91% | -59.46M 396,138.62% | -125.75M 111.50% | -157.04M 24.88% | -98.79M 37.09% | |
income tax expense | 3.70M - | -13.11M 453.93% | -716.10K 94.54% | 2.05M 385.68% | 4.59M 124.38% | -1.38M - | 48.32K 103.50% | -2.66M 5,604.12% | |||
net income | -20.80M - | -2.97M 85.70% | -6.29M 111.33% | -8.96M 42.54% | -17.32M 93.26% | -15.01K 99.91% | -59.46M 396,138.62% | -125.75M 111.50% | -157.04M 24.88% | -98.79M 37.09% | |
weighted average shs out | 2.49M - | 2.90M 16.68% | 3.02M 4.10% | 3.14M 3.90% | 6.31M 101.25% | 9.23K 99.85% | 15.59M 168,869.86% | 17.55M 12.56% | 29.63M 68.80% | 30.10M 1.59% | |
weighted average shs out dil | 2.49M - | 2.90M 16.68% | 3.02M 4.10% | 3.14M 3.90% | 6.31M 101.25% | 9.23K 99.85% | 15.59M 168,867.66% | 17.55M 12.56% | 29.63M 68.80% | 30.10M 1.59% | |
eps | -8.37 - | -1.03 87.69% | -2.08 101.94% | -2.86 37.50% | -2.74 4.20% | -1.63 40.51% | -3.81 133.74% | -7.16 87.93% | -5.30 25.98% | -3.28 38.11% | |
epsdiluted | -8.37 - | -1.03 87.69% | -2.08 101.94% | -2.86 37.50% | -2.74 4.20% | -1.63 40.51% | -3.81 133.74% | -7.16 87.93% | -5.30 25.98% | -3.28 38.11% |
All numbers in (except ratios and percentages)